Activation of the Raf/MEK/ERK signaling pathway has also been observed in pituitary adenomas, as demonstrated by the finding that B-Raf is overexpressed, and its downstream effectors MEK1/2 and ERK1/2 overactivated, in pituitary adenomas (75, 76). The gene discussed is MAP2K7; the disease is pituitary gland adenoma.